Shares of vaccine makers Pfizer Inc., GSK PLC and Moderna Inc. dropped Wednesday as advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinate
Pfizer just whiffed one of its late-stage clinical trials. Sarepta Therapeutics just got regulators to sign off on a similar program.

3 Blue-Chip Stocks to Buy on the Dip: June 2024

06:33am, Wednesday, 26'th Jun 2024
Wagering on the top blue-chip stocks to buy on the dip might be the best way to play the current stock market trends. Blue-chip stocks typically offer a superb blend of reliability and growth potentia
Pfizer (PFE) closed at $27.99 in the latest trading session, marking a -1.3% move from the prior day.
Novo Nordisk is raking in billions from Ozempic and Wegovy. Pfizer wants in on the action, so it's teaming up with a biotech.
Many high-quality companies pay dividends currently yielding over 5%. Several also have excellent records of increasing their high-yielding dividends.
Artificial intelligence (AI) has the potential to add nearly $16 trillion to the global economy by the turn of the decade. Eight top-tier billionaires sent shares of Nvidia to the chopping block in th
There are multiple reasons to consider exposure to pharmaceutical stocks for the long-term portfolio. First, pharma stocks have a low-beta and provide and help in reducing the overall beta of a portfo

3 Undervalued Dividend Stocks to Buy in June

10:20am, Monday, 24'th Jun 2024
24/7 Insights Dividend stocks can supply investors with a steady stream of passive income.
Healthcare and beauty are both explosive industries -- and potential hunting grounds for good stocks. Pfizer is navigating the aftermath of its pandemic successes, but a much brighter future could be

7 Dividend Stocks to Buy Now: June 2024

01:38pm, Sunday, 23'rd Jun 2024
Income-oriented investors love finding dividend stocks to buy now. That's particularly true when those stocks are on sale, as many continue to be.
Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically re
AT&T's dividend hasn't risen in a while due to a heavy debt load, but there could be plenty of progress in the years ahead. With a dividend yield above 10% at recent prices, PennantPark Floating Rate

Investing for the Next 12 Months? Buy These

01:23pm, Saturday, 22'nd Jun 2024
If investors expect interest rates to hold until next year, they should consider dividend-yielding stocks like Altria (NYSE: MO), Bristol Myers, and Pfizer (NYSE: PFE), which offer reasonable values a
AstraZeneca should have lots of growth ahead. Bristol Myers Squibb has what it takes to navigate a major patent cliff.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE